BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 29848133)

  • 1. Therapeutic strategies for upper tract urothelial carcinoma.
    Freifeld Y; Krabbe LM; Clinton TN; Woldu SL; Margulis V
    Expert Rev Anticancer Ther; 2018 Aug; 18(8):765-774. PubMed ID: 29848133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advancements in the clinical management of upper tract urothelial carcinoma.
    Taylor J; Meng X; Ghandour R; Margulis V
    Expert Rev Anticancer Ther; 2019 Dec; 19(12):1051-1060. PubMed ID: 31770492
    [No Abstract]   [Full Text] [Related]  

  • 3. Urothelial carcinoma of the bladder and the upper tract: disparate twins.
    Green DA; Rink M; Xylinas E; Matin SF; Stenzl A; Roupret M; Karakiewicz PI; Scherr DS; Shariat SF
    J Urol; 2013 Apr; 189(4):1214-21. PubMed ID: 23023150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urothelial cancer of the urinary bladder: can lessons learned be applied to the upper urinary tract?
    Krabbe LM; Hutchinson RC; Margulis V
    Minerva Urol Nefrol; 2016 Aug; 68(4):396-408. PubMed ID: 26990295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update.
    Rouprêt M; Babjuk M; Compérat E; Zigeuner R; Sylvester RJ; Burger M; Cowan NC; Böhle A; Van Rhijn BW; Kaasinen E; Palou J; Shariat SF
    Eur Urol; 2015 Nov; 68(5):868-79. PubMed ID: 26188393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoscopic management of upper-tract urothelial carcinoma.
    Raman JD; Park R
    Expert Rev Anticancer Ther; 2017 Jun; 17(6):545-554. PubMed ID: 28480774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Organ preservation in cancer of the upper urinary tract].
    Vom Dorp F
    Urologe A; 2019 Jan; 58(1):22-24. PubMed ID: 30649581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis, management, and follow-up of upper tract urothelial carcinoma: an interdisciplinary collaboration between urology and radiology.
    Roberts JL; Ghali F; Aganovic L; Bechis S; Healy K; Rivera-Sanfeliz G; Autorino R; Derweesh I
    Abdom Radiol (NY); 2019 Dec; 44(12):3893-3905. PubMed ID: 31701194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of instillations with chemotherapy or immunotherapy following endoscopic resection for upper tract urothelial carcinoma.
    Bachir BG; Kassouf W
    Expert Rev Anticancer Ther; 2012 Jan; 12(1):63-75. PubMed ID: 22149433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracavitary therapies for upper tract urothelial carcinoma.
    Knoedler JJ; Raman JD
    Expert Rev Clin Pharmacol; 2018 May; 11(5):487-493. PubMed ID: 29634361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update.
    Rouprêt M; Babjuk M; Compérat E; Zigeuner R; Sylvester RJ; Burger M; Cowan NC; Gontero P; Van Rhijn BWG; Mostafid AH; Palou J; Shariat SF
    Eur Urol; 2018 Jan; 73(1):111-122. PubMed ID: 28867446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upper urinary tract recurrence following bladder cancer therapy: a review of surveillance and management.
    Naser-Tavakolian A; Ghodoussipour S; Djaladat H
    Curr Opin Urol; 2019 May; 29(3):189-197. PubMed ID: 30762673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review.
    Cutress ML; Stewart GD; Zakikhani P; Phipps S; Thomas BG; Tolley DA
    BJU Int; 2012 Sep; 110(5):614-28. PubMed ID: 22471401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organ-sparing procedures in GU cancer: part 3-organ-sparing procedures in urothelial cancer of upper tract, bladder and urethra.
    Khalil MI; Alliston JT; Bauer-Erickson JJ; Davis R; Bissada NK; Kamel MH
    Int Urol Nephrol; 2019 Nov; 51(11):1903-1911. PubMed ID: 31352580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of upper urinary tract urothelial carcinoma.
    Sun M; Abdo A; Abdollah F; Schmitges J; Thuret R; Jeldres C; Shariat SF; Perrotte P; Karakiewicz PI
    Expert Rev Anticancer Ther; 2010 Dec; 10(12):1955-65. PubMed ID: 21110761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upper tract urothelial carcinoma: special considerations.
    Hutchinson R; Haddad A; Sagalowsky A; Margulis V
    Clin Adv Hematol Oncol; 2016 Feb; 14(2):101-9. PubMed ID: 27057809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bladder cancer following upper tract urothelial carcinoma.
    Kauffman EC; Raman JD
    Expert Rev Anticancer Ther; 2008 Jan; 8(1):75-85. PubMed ID: 18095885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant Therapy in Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Carcinoma.
    Achkar T; Parikh RA
    Urol Clin North Am; 2018 May; 45(2):257-266. PubMed ID: 29650141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of Oligometastatic and Locally Recurrent Urothelial Carcinoma.
    Liu MA; Li JW; Runcie K
    Curr Oncol Rep; 2024 May; 26(5):496-503. PubMed ID: 38602581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.